패혈증 진단약 시장 규모, 점유율, 성장 분석 : 기술별, 용도별, 제품별, 방법별, 병원체 유형별, 검사 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Sepsis Diagnostics Market Size, Share, and Growth Analysis, By Technology, By Application, By Product, By Method, By Pathogen Type, By Test Type, By End Users, By Region - Industry Forecast 2025-2032
상품코드:1663838
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
패혈증 진단약 시장 규모는 2023년에 6억 9,000만 달러로 평가되며, 2024년 7억 5,000만 달러에서 2032년에는 14억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 8.7%로 성장할 전망입니다.
패혈증 진단 시장은 고령자 및 면역결핍증 환자 등 고위험군의 감염 관련 입원 건수 증가로 인해 헬스케어 분야에서 중요한 분야로 부상하고 있습니다. 멀티플렉스 분석 및 신속 PCR 검사 등의 기술 발전으로 검출 속도와 정확도가 향상되고 있으며, 규제 당국의 노력으로 패혈증 관리 방법의 개선이 촉진되고 있습니다. 이러한 성장 잠재력에도 불구하고 비특이적 증상으로 인한 패혈증 진단의 복잡성과 진단 검사 비용의 상승으로 인해 자원이 부족한 환경에서의 활용이 제한되고 있습니다. 또한 다양한 검사 프로토콜과 표준화의 필요성은 혁신적인 기술의 채택을 방해할 수 있습니다. 그러나 새로운 바이오마커 개발, 신속한 검사 솔루션, AI와 머신러닝의 통합, 공동 연구 및 개발 노력에는 기회가 존재합니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
패혈증 진단약 시장 규모 : 기술별 & CAGR(2025-2032)
시장 개요
혈액 배양 기술
패혈증 진단약 시장 규모 : 용도별 & CAGR(2025-2032)
시장 개요
병원
진단 센터
패혈증 진단약 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
혈액 배양 배지
어세이 및 시약 키트
기기
소프트웨어
패혈증 진단약 시장 규모 : 방법별 & CAGR(2025-2032)
시장 개요
기존 진단
자동 진단
패혈증 진단약 시장 규모 : 병원체 유형별 & CAGR(2025-2032)
시장 개요
세균성 패혈증
그람음성 세균성 패혈증
그람양성 세균성 패혈증 진균성 패혈증
기타 병원체 유형
패혈증 진단약 시장 규모 : 검사 유형별 & CAGR(2025-2032)
시장 개요
임상 검사
POC(Point of Care) 검사
패혈증 진단약 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
병원과 전문 클리닉
병리학 및 기준 연구실
조사실
학술기관
패혈증 진단약 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
BioMerieux SA(France)
Becton, Dickinson and Company(BD)(USA)
Thermo Fisher Scientific, Inc.(USA)
F. Hoffmann-La Roche AG(Switzerland)
Danaher Corporation(Beckman Coulter, Inc.)(USA)
Bruker Corporation(USA)
Abbott Laboratories, Inc.(USA)
Cepheid(USA)
Luminex Corporation(USA)
T2 Biosystems, Inc.(USA)
Siemens Healthineers(Germany)
Qiagen N.V.(Netherlands)
Immunexpress, Inc.(USA)
Seegene Inc.(South Korea)
Koninklijke Philips N.V.(Netherlands)
GenMark Diagnostics(USA)
Wolters Kluwer NV.(Netherlands)
Epic Systems Corporation.(USA)
McKesson Corporation.(USA)
결론과 제안
KSA
영문 목차
영문목차
Sepsis Diagnostics Market size was valued at USD 0.69 billion in 2023 and is poised to grow from USD 0.75 billion in 2024 to USD 1.46 billion by 2032, growing at a CAGR of 8.7% during the forecast period (2025-2032).
The sepsis diagnostics market is a crucial segment of the healthcare sector, driven by rising infection-related hospitalizations among high-risk populations, including the elderly and immunocompromised individuals. Technological advancements such as multiplex assays and rapid PCR tests are enhancing detection speed and accuracy, while regulatory initiatives are fostering improved sepsis management practices. Despite this growth potential, challenges such as high diagnostic test costs limit accessibility in resource-constrained settings, alongside the complexity of sepsis diagnosis due to its non-specific symptoms. Additionally, varying testing protocols and the need for standardization may hinder the adoption of innovative technologies. However, opportunities exist in the development of new biomarkers, rapid testing solutions, and the integration of AI and machine learning, along with collaborative research and development efforts.
Top-down and bottom-up approaches were used to estimate and validate the size of the Sepsis Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Sepsis Diagnostics Market Segments Analysis
Global Sepsis Diagnostics Market is segmented by Technology, Application, Product, Method, Pathogen Type, Test Type, End Users and region. Based on Technology, the market is segmented into Blood Culture Technology. Based on Application, the market is segmented into Hospitals and Diagnostics Centres. Based on Product, the market is segmented into Blood Culture Media, Assays and Reagent Kits, Instruments and Software. Based on Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Based on Pathogen Type, the market is segmented into Bacterial Sepsis and Other Pathogen Types. Based on Test Type, the market is segmented into Laboratory Tests and Point-Of-Care Tests. Based on End Users, the market is segmented into Hospitals And Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories and Academic Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Sepsis Diagnostics Market
The Sepsis Diagnostics market is significantly driven by the rising awareness and training initiatives aimed at healthcare professionals, emphasizing the importance of early sepsis detection and management. This growing focus is leading to a higher uptake of diagnostic tests and related services. Additionally, there has been a surge in public education campaigns highlighting the symptoms and signs of sepsis, which encourages individuals to seek timely medical attention. As a result, this proactive approach not only fosters prompt diagnosis but also enhances testing frequencies, further stimulating the overall growth of the Sepsis Diagnostics market.
Restraints in the Sepsis Diagnostics Market
The Sepsis Diagnostics market faces significant challenges due to the diverse and non-specific signs and symptoms associated with sepsis, which complicate early diagnosis. This complexity can lead to delays in treatment or misdiagnosis, undermining the effectiveness of diagnostic tools. Furthermore, accurate sepsis diagnosis often requires a combination of tests, which adds to the complexity and extends the turnaround time for results. This protracted process can hamper patient outcomes and diminish the perceived value of diagnostic solutions, ultimately restraining the growth and development of the Sepsis Diagnostics market. Addressing these issues is crucial for improving diagnostic efficiency and market expansion.
Market Trends of the Sepsis Diagnostics Market
The Sepsis Diagnostics market is witnessing a significant trend towards the adoption of advanced molecular diagnostic techniques, particularly next-generation sequencing (NGS) and polymerase chain reaction (PCR). These methodologies are revolutionizing pathogen detection by providing accurate and rapid results, drastically reducing the time for diagnosis compared to traditional culture methods. This shift is critical in sepsis management, as early intervention greatly enhances patient outcomes. As healthcare providers increasingly prioritize timely diagnostics, the demand for these innovative technologies is surging, positioning them as essential components in combating sepsis and driving overall market growth. The focus on precision medicine further amplifies this trend, promising enhanced efficacy in treatment protocols.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Sepsis Diagnostics Market Size by Technology & CAGR (2025-2032)
Market Overview
Blood Culture Technology
Global Sepsis Diagnostics Market Size by Application & CAGR (2025-2032)
Market Overview
Hospitals
Diagnostics Centres
Global Sepsis Diagnostics Market Size by Product & CAGR (2025-2032)
Market Overview
Blood Culture Media
Assays and Reagent Kits
Instruments
Software
Global Sepsis Diagnostics Market Size by Method & CAGR (2025-2032)
Market Overview
Conventional Diagnostics
Automated Diagnostics
Global Sepsis Diagnostics Market Size by Pathogen Type & CAGR (2025-2032)
Market Overview
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis Fungal Sepsis
Other Pathogen Types
Global Sepsis Diagnostics Market Size by Test Type & CAGR (2025-2032)
Market Overview
Laboratory Tests
Point-Of-Care Tests
Global Sepsis Diagnostics Market Size by End Users & CAGR (2025-2032)
Market Overview
Hospitals And Speciality Clinics
Pathology and Reference Laboratories
Research Laboratories
Academic Institute
Global Sepsis Diagnostics Market Size & CAGR (2025-2032)
North America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
US
Canada
Europe (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
Brazil
Rest of Latin America
Middle East & Africa (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
